Related Experiment Video
Updated: Jun 26, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer
Sarah J Zardawi1, Sandra A O'Toole, Robert L Sutherland
1Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, Australia.
Abstract:
There has been a significant decrease in mortality from breast cancer in the last two decades. This has been attributed to the introduction of mammographic screening and to the development of specialised therapies, notably anti-estrogens such as tamoxifen in estrogen receptor (ER) positive tumours, and adjuvant chemotherapy. More recently monoclonal antibodies such as trastuzumab directed against Her2-overexpressing tumours show significant promise in improving outcome from this aggressive subtype. While there have been significant advances, a number of clinical challenges still remain, particularly development of targeted therapies for other forms of breast cancer lacking ER or Her2, such as the aggressive basal-like carcinomas. Identification of new therapeutic targets in poor prognosis groups will be critical to further improvements in breast cancer treatment. Proper functioning of the Hedgehog, Notch and Wnt signalling pathways is required for normal development during early life and these pathways also play a key role in regulation and maintenance of stem cells. Increasing evidence implicates dysregulation of these pathways in the development and progression of a number of malignancies, including breast cancer. This review presents the current evidence for aberrations in these pathways in breast cancer and proposes that the Hedgehog, Notch and Wnt signalling pathways may represent novel therapeutic targets.
Insights
Advances in breast cancer treatment have reduced mortality, but new therapies are needed for aggressive subtypes. This review explores Hedgehog, Notch, and Wnt pathways as potential novel therapeutic targets for breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Breast cancer mortality has decreased due to screening and targeted therapies like tamoxifen and trastuzumab.
- Significant challenges remain in treating aggressive breast cancer subtypes lacking estrogen receptor (ER) or Her2 expression, such as basal-like carcinomas.
- Novel therapeutic targets are crucial for improving outcomes in poor-prognosis breast cancer groups.
Purpose of the Study:
- To review the current evidence for dysregulation of Hedgehog, Notch, and Wnt signaling pathways in breast cancer.
- To propose these pathways as potential novel therapeutic targets for breast cancer treatment.
Main Methods:
- Literature review of current evidence on signaling pathway aberrations in breast cancer.
- Analysis of the role of Hedgehog, Notch, and Wnt pathways in normal development and stem cell regulation.
- Exploration of the implications of pathway dysregulation in breast cancer pathogenesis.
Main Results:
- Hedgehog, Notch, and Wnt signaling pathways are essential for normal development and stem cell maintenance.
- Aberrations in these pathways are increasingly implicated in the development and progression of various malignancies, including breast cancer.
- Evidence suggests these pathways are dysregulated in aggressive breast cancer subtypes.
Conclusions:
- The Hedgehog, Notch, and Wnt signaling pathways represent promising novel therapeutic targets for breast cancer.
- Targeting these pathways could lead to improved treatment strategies for aggressive and difficult-to-treat breast cancer forms.
- Further research into targeting these pathways is warranted to enhance breast cancer treatment outcomes.
Related Concept Videos
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway

